Effect of Tumor Microenvironment on Tumor VEGF During Anti-VEGF Treatment: Systems Biology Predictions

Circulating vascular endothelial growth factor (VEGF) as a biomarker for bevacizumab-based therapy in metastatic colorectal, non-small cell lung, and renal cell cancers: Analysis of phase III studies.

(2017) C. Bernaards et al.   JOURNAL OF CLINICAL ONCOLOGY

Plasma levels of VEGF-A and VEGFR-2 in advanced NSCLC.

(2017) E. Sanmartin et al.   JOURNAL OF CLINICAL ONCOLOGY

The Effect of Bevacizumab on Human Malignant Melanoma Cells with Functional VEGF/VEGFR2 Autocrine and Intracrine Signaling Loops

(2015) Una Adamcic et al.   NEOPLASIA

Predicting the Effects of Anti-angiogenic Agents Targeting Specific VEGF Isoforms

(2012) Stacey D. Finley et al.   AAPS Journal

VEGF Exerts an Angiogenesis-Independent Function in Cancer Cells to Promote Their Malignant Progression

(2012) Ying Cao et al.   CANCER RESEARCH

Intense intermittent exercise provides weak stimulus for vascular endothelial growth factor secretion and capillary growth in skeletal muscle

(2012) B. Hoier et al.   EXPERIMENTAL PHYSIOLOGY

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial

(2012) Eric Van Cutsem et al.   JOURNAL OF CLINICAL ONCOLOGY

Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner

(2012) Vikash P. Chauhan et al.   Nature Nanotechnology

Antiangiogenic therapy—evolving view based on clinical trial results

(2012) Gordon C. Jayson et al.   Nature Reviews Clinical Oncology

Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis

(2011) E. M. Battinelli et al.   BLOOD

Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies

(2011) Stacey D Finley et al.   BMC Systems Biology

Blockade of VEGF-A suppresses tumor growth via inhibition of autocrine signaling through FAK and AKT

(2011) Jungwhoi Lee et al.   CANCER LETTERS

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Overexpression of VEGF 165 b, an Inhibitory Splice Variant of Vascular Endothelial Growth Factor, Leads to Insufficient Angiogenesis in Patients With Systemic Sclerosis

(2011) Mirko Manetti et al.   CIRCULATION RESEARCH

The VEGF 165 b “ICE-o-form” Puts a Chill on the VEGF Story

(2011) Ayotunde O. Dokun et al.   CIRCULATION RESEARCH

Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast Cancer

(2011) A. M. Jubb et al.   CLINICAL CANCER RESEARCH

Pro- and anti-angiogenic factors in human skeletal muscle in response to acute exercise and training

(2011) B. Hoier et al.   JOURNAL OF PHYSIOLOGY-LONDON

VEGF121b and VEGF165b are weakly angiogenic isoforms of VEGF-A

(2011) Raúl Catena et al.   Molecular Cancer

Functional and Structural Characteristics of Tumor Angiogenesis in Lung Cancers Overexpressing Different VEGF Isoforms Assessed by DCE- and SSCE-MRI

(2011) Ang Yuan et al.   PLoS One

Proteomic Analysis of Ovarian Cancer Proximal Fluids: Validation of Elevated Peroxiredoxin 1 in Patient Peripheral Circulation

(2011) Ebony R. Hoskins et al.   PLoS One

Effect of Vascular Endothelial Growth Factor Inhibition on Endometrial Implant Development in a Murine Model of Endometriosis

(2011) Analía Gabriela Ricci et al.   Reproductive Sciences

Increase of Plasma VEGF after Intravenous Administration of Bevacizumab Is Predicted by a Pharmacokinetic Model

(2010) M. O. Stefanini et al.   CANCER RESEARCH

Cationic liposome coupled endostatin gene for treatment of peritoneal colon cancer

(2010) Keng-Li Lan et al.   CLINICAL & EXPERIMENTAL METASTASIS

Network Systems Biology for Drug Discovery

(2010) D K Arrell et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The effect of passive movement training on angiogenic factors and capillary growth in human skeletal muscle

(2010) B. Høier et al.   JOURNAL OF PHYSIOLOGY-LONDON

Therapeutic potential of manipulating VEGF splice isoforms in oncology

(2009) Emma S Rennel et al.   Future Oncology

Serum Vascular Endothelial Growth Factor/Soluble Vascular Endothelial Growth Factor Receptor 1 Ratio Is an Independent Prognostic Marker in Pancreatic Cancer

(2009) Yu-Ting Chang et al.   PANCREAS

In vivo measurement of tumor estradiol and Vascular Endothelial Growth Factor in breast cancer patients

(2008) Stina Garvin et al.   BMC CANCER

Blood Vessel Maturation and Response to Vascular-Disrupting Therapy in Single Vascular Endothelial Growth Factor-A Isoform-Producing Tumors

(2008) G. M. Tozer et al.   CANCER RESEARCH

A New ELISA for Use in a 3-ELISA System to Assess Concentrations of VEGF Splice Variants and VEGF110 in Ovarian Cancer Tumors

(2008) J. Gutierrez et al.   CLINICAL CHEMISTRY

Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors

(2008) D. G. Nowak et al.   JOURNAL OF CELL SCIENCE

Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients

(2008) Zeki Ustuner et al.   MEDICAL ONCOLOGY

Angiogenic molecule Tie-2 and VEGF in the pathogenesis of pleural effusions

(2008) Foteini Economidou et al.   RESPIRATORY MEDICINE

Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions

(2008) Bernard C. Duysinx et al.   RESPIRATORY MEDICINE

Vascular endothelial growth factor levels in ascites between chemonaive and chemotreated patients

(2008) Hae Kyung Lee et al.   YONSEI MEDICAL JOURNAL

Passive leg movement enhances interstitial VEGF protein, endothelial cell proliferation, and eNOS mRNA content in human skeletal muscle

(2007) Ylva Hellsten et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY